Calls Now Open

2022 ADDF-Harrington and 2023 Harrington UK Rare Disease Programs

You've just added:

January 18, 2018

Harrington Discovery Institute at University Hospitals Announces 2018 Grant Funding to 10 Physician-Scientists

January 18, 2018, Cleveland, Ohio – The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2018 Harrington Scholar-Innovator Award recipients. The awards support breakthrough discoveries in diverse research areas including cancer, diabetes, osteoporosis, and addiction.

The Harrington Discovery Institute – part of The Harrington Project for Discovery & Development – fulfills an unmet need in academic medicine: to advance early breakthroughs into the clinical realm. Award recipients are selected for the promise of their research to advance standards of care in medicine, regardless of their institution affiliation.

In addition to financial support awarded to the winners, the Harrington Discovery Institute provides guidance in all aspects of drug discovery from its Innovation Support Center. This is a team of pharmaceutical industry experts who oversee the therapeutic development of Scholar programs. While working with the Harrington Discovery Institute, physician-scientists (and their institutions) retain the intellectual property for their work.

“This extraordinary group of physician-scientists constitutes our sixth class of Harrington Scholar-Innovators. We selected these projects from a highly competitive pool of applications based on their potential to advance from discoveries into medicines that will improve human health,” said Jonathan Stamler, MD, President of the Harrington Discovery Institute.

The selected scholars have access to several rounds of capital (up to a total of $700,000) through their affiliation with the Harrington Discovery Institute to support the transition of their work into the private sector. Scholars are then free to approach investors of their choice to underwrite the commercialization of their work. They also have facilitated access to BioMotiv, the mission-aligned development company that is part of The Harrington Project. However, there are no obligations on either side.

“We hear from our scholars that the tailored guidance they receive throughout the program and the connection to a for-profit accelerator are vital to success,” added Dr. Stamler. “We News Release Department of Marketing and Communications 11100 Euclid Avenue Cleveland, OH 44106 Contact: George Stamatis Phone: 216-844-3667 Email: george.stamatis@uhhospitals.org know that our model works, and we are pleased to see the results, which to date include launching twenty companies, assisting five programs in entering the clinic, and licensing five technologies to big pharma.”

The 2018 Harrington Scholar-Innovator Award recipients are:

Suneet Agarwal, MD, PhD - Boston Children's Hospital Modulators of telomere diseases

Jeffrey Glenn, MD, PhD - Stanford University School of Medicine A broad spectrum single dose therapeutic to treat flu

Wayne Lencer, MD - Boston Children's Hospital Novel strategy to treat type 2 diabetes

Robert Messing, MD - University of Texas at Austin New therapeutic to treat pain and addiction

Victor Schuster, MD - Albert Einstein College of Medicine Targeting nonalcoholic liver diseases

Bhuvanesh Singh, MD, PhD - Memorial Sloan-Kettering Cancer Center Novel agents to treat cancers of the head, neck, and lung

David Sykes, MD, PhD - Massachusetts General Hospital Developing new treatments for leukemia

Marc Wein, MD, PhD - Massachusetts General Hospital A new therapeutic to prevent osteoporosis

Adrian Wiestner, MD, PhD - NHLBI/NIH Enhancing the potency of antibody therapeutics for cancer

Mone Zaidi, MD, PhD - Icahn School of Medicine at Mount Sinai A single agent to treat obesity and osteoporosis

About the Scholars

Bhuvanesh Singh

Oncology

Bhuvanesh Singh, MD, PhD

Memorial Sloan Kettering Cancer Center
2018 Harrington Scholar-Innovator

More about Bhuvanesh Singh

Mone Zaidi

Metabolic, Musculoskeletal

Mone Zaidi, MD, PhD

Icahn School of Medicine at Mount Sinai
2018 Harrington Scholar-Innovator

More about Mone Zaidi

Adrian Wiestner

Oncology

Adrian Wiestner, MD, PhD

NHLBI/NIH
2018 Harrington Scholar-Innovator

More about Adrian Wiestner

Marc  Wein

Endocrine, Musculoskeletal

Marc Wein, MD, PhD

Massachusetts General Hospital
2018 Harrington Scholar-Innovator

More about Marc Wein

David Sykes

Oncology

David Sykes, MD, PhD

Massachusetts General Hospital
2018 Harrington Scholar-Innovator

More about David Sykes

Victor Schuster

Metabolic

Victor Schuster, MD

Albert Einstein College of Medicine
2018 Harrington Scholar-Innovator

More about Victor Schuster

Robert Messing

Neuroscience

Robert Messing, MD

University of Texas at Austin
2018 Harrington Scholar-Innovator

More about Robert Messing

Wayne Lencer

Metabolic

Wayne Lencer, MD

Boston Children’s Hospital
2018 Harrington Scholar-Innovator

More about Wayne Lencer

Jeffrey Glenn

Infectious Disease

Jeffrey Glenn, MD, PhD

Stanford University
2018 Harrington Scholar-Innovator

More about Jeffrey Glenn

Suneet Agarwal

Hematology, Rare/Orphan, Regenerative

Suneet Agarwal, MD, PhD

Boston Children’s Hospital
2018 Harrington Scholar-Innovator

More about Suneet Agarwal